Patents by Inventor Ravinder Reddy KONDREDDI
Ravinder Reddy KONDREDDI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210032202Abstract: A compound of Formula (1) is provided that has been shown to be useful for treating a disease, disorder or syndrome that is mediated by the transportation of essential molecules in the mmpL3 pathway: wherein R1, R2, R3, R4, R5 and R6 are as defined herein.Type: ApplicationFiled: June 12, 2020Publication date: February 4, 2021Inventors: Jan JIRICEK, Ravinder Reddy KONDREDDI, Paul William SMITH
-
Publication number: 20180230145Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a Plasmodium parasite, such as malaria.Type: ApplicationFiled: February 6, 2018Publication date: August 16, 2018Inventors: Arnab Kumar CHATTERJEE, Advait Suresh NAGLE, Prasuna PARASELLI, Ravinder Reddy KONDREDDI, Seh Yong LEONG, Pranab Kumar MISHRA, Robert Joseph MOREAU, Jason Thomas ROLAND, Wei Lin Sandra SIM, Oliver SIMON, Liying Jocelyn TAN, Bryan KS YEUNG, Bin ZOU, Venkatataiah BOLLU
-
Patent number: 9926314Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a Plasmodium parasite, such as malaria.Type: GrantFiled: July 26, 2016Date of Patent: March 27, 2018Assignee: Novartis AGInventors: Arnab Kumar Chatterjee, Advait Suresh Nagle, Prasuna Paraselli, Ravinder Reddy Kondreddi, Seh Yong Leong, Pranab Kumar Mishra, Robert Joseph Moreau, Jason Thomas Roland, Wei Lin Sandra Sim, Oliver Simon, Liying Jocelyn Tan, Bryan K S Yeung, Bin Zou, Venkatataiah Bollu
-
Patent number: 9556169Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a Plasmodium parasite, such as malaria.Type: GrantFiled: November 18, 2013Date of Patent: January 31, 2017Assignee: Novartis AGInventors: Arnab Kumar Chatterjee, Advait Suresh Nagle, Prasuna Paraselli, Ravinder Reddy Kondreddi, Seh Yong Leong, Pranab Kumar Mishra, Robert Joseph Moreau, Jason Thomas Roland, Wei Lin Sandra Sim, Oliver Simon, Jocelyn Liying Tan, Bryan K S Yeung, Bin Zou, Venkatataiah Bollu
-
Patent number: 9546138Abstract: A compound of Formula (I) is provided that has been shown to be useful for treating a disease, disorder or syndrome that is mediated by the inhibition of mycolic acid biosynthesis through inhibition of M. tuberculosis Enoyl Acyl Carrier Protein Reductase enzyme (InhA): wherein R1, R2, R3, R4 and R5 are as defined herein.Type: GrantFiled: December 12, 2013Date of Patent: January 17, 2017Assignee: Novartis AGInventors: Ravinder Reddy Kondreddi, Ngai Ling Ma, Stefan Peukert, Srinivasa P S Rao, Manjunatha Ujjini
-
Publication number: 20160355477Abstract: A compound of Formula (I) is provided that has been shown to be useful for treating a disease, disorder or syndrome that is mediated by the transportation of essential molecules in the mmpL3 pathway: wherein R1, R2, R3, R4, R5 and R6 are as defined herein.Type: ApplicationFiled: August 19, 2016Publication date: December 8, 2016Applicant: NOVARTIS AGInventors: Jan Jiricek, Ravinder Reddy Kondreddi, Paul William Smith
-
Publication number: 20160333012Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a Plasmodium parasite, such as malaria.Type: ApplicationFiled: July 26, 2016Publication date: November 17, 2016Applicant: NOVARTIS AGInventors: Arnab Kumar CHATTERJEE, Advait Suresh NAGLE, Prasuna Paraselli, Ravinder Reddy KONDREDDI, Seh Yong LEONG, Pranab Kumar MISHRA, Robert Joseph MOREAU, Jason Thomas ROLAND, Wei Lin Sandra SIM, Oliver SIMON, Jocelyn Liying TAN, Bryan KS YEUNG, Bin ZOU, Venkatataiah BOLLU
-
Patent number: 9447039Abstract: A compound of Formula (I) is provided that has been shown to be useful for treating a disease, disorder or syndrome that is mediated by the transportation of essential molecules in the mmpL3 pathway: wherein R1, R2, R3, R4, R5 and R6 are as defined herein.Type: GrantFiled: September 5, 2013Date of Patent: September 20, 2016Assignee: Novartis AGInventors: Jan Jiricek, Ravinder Reddy Kondreddi, Paul William Smith
-
Publication number: 20150344471Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a Plasmodium parasite, such as malaria.Type: ApplicationFiled: November 18, 2013Publication date: December 3, 2015Applicant: NOVARTIS AGInventors: Arnab Kumar CHATTERJEE, Advait Suresh NAGLE, Prasuna PARASELLI, Ravinder Reddy KONDREDDI, Seh Yong LEONG, Pranab Kumar MISHRA, Robert Joseph MOREAU, Jason Thomas ROLAND, Wei Lin Sandra SIM, Olive SIMON, Liying Jocelyn TAN, Bryan KS YEUNG, Bin ZOU, Venkatataiah BOLLU
-
Publication number: 20150291526Abstract: A compound of Formula (I) is provided that has been shown to be useful for treating a disease, disorder or syndrome that is mediated by the inhibition of mycolic acid biosynthesis through inhibition of M. tuberculosis Enoyl Acyl Carrier Protein Reductase enzyme (InhA): wherein R1, R2, R3, R4 and R5 are as defined herein.Type: ApplicationFiled: December 12, 2013Publication date: October 15, 2015Applicant: Novartis AGInventors: Ravinder Reddy KONDREDDI, Ujjini H. MANJUNATHA, Ngai Ling MA, Stefan PEUKERT, Srinivasa PS RAO
-
Publication number: 20150175539Abstract: A compound of Formula (I) is provided that has been shown to be useful for treating a disease, disorder or syndrome that is mediated by the transportation of essential molecules in the mmpL3 pathway: wherein R1, R2, R3, R4, R5 and R6 are as defined herein.Type: ApplicationFiled: September 5, 2013Publication date: June 25, 2015Applicant: Novartis AGInventors: Jan Jiricek, Ravinder Reddy Kondreddi, Paul William Smith
-
Publication number: 20150011522Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a Plasmodium parasite, such as malaria.Type: ApplicationFiled: September 22, 2014Publication date: January 8, 2015Applicants: IRM LLC, Novartis AGInventors: Arnab Kumar Chatterjee, Advait Suresh Nagle, Prasuna Paraselli, Ravinder Reddy Kondreddi, Seh Yong Leong, Pranab Kumar Mishra, Robert Joseph Moreau, Jason Thomas Roland, Wei Lin Sandra Sim, Oliver Simon, Liying Jocelyn Tan, Bryan KS Yeung, Bin Zou, Venkatataiah Bollu
-
Patent number: 8871754Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a Plasmodium parasite, such as malaria.Type: GrantFiled: November 18, 2013Date of Patent: October 28, 2014Assignees: IRM LLC, Novartis AGInventors: Arnab Kumar Chatterjee, Advait Suresh Nagle, Prasuna Paraselli, Ravinder Reddy Kondreddi, Seh Yong Leong, Pranab Kumar Mishra, Robert Joseph Moreau, Jason Thomas Roland, Wei Lin Sandra Sim, Oliver Simon, Liying Jocelyn Tan, Bryan K S Yeung, Bin Zou, Venkatataiah Bollu
-
Publication number: 20140155367Abstract: The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a Plasmodium parasite, such as malaria.Type: ApplicationFiled: November 18, 2013Publication date: June 5, 2014Applicants: Novartis AG, IRM LLCInventors: Arnab Kumar Chatterjee, Advait Suresh Nagle, Prasuna Paraselli, Ravinder Reddy Kondreddi, Seh Yong Leong, Pranab Kumar Mishra, Robert Joseph Moreau, Jason Thomas Roland, Wei Lin Sandra Sim, Oliver Simon, Liying Jocelyn Tan, Bryan KS Yeung, Bin Zou, Venkatataiah Bollu
-
Publication number: 20100144655Abstract: This invention relates to novel compounds that have various medicinal applications, e.g. for the treatment and/or prevention of viral infections.Type: ApplicationFiled: August 6, 2009Publication date: June 10, 2010Applicant: NOVARTIS AGInventors: Yen Liang CHEN, Jeyaraj DURAISWAMY, Sarah HALLER, Matthias KEIM, Ravinder Reddy KONDREDDI, Zheng YIN